PFM
WVE icon

Privium Fund Management’s Wave Life Sciences WVE Stock Holding History

Privium Fund Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Hold
241,010
– – 0.26% 40
2026
Q1 		$1.75M Buy
241,010
+48,000
+25% +$625K 0.36% 35
2025
Q4 		$3.28M Buy
193,010
+23,010
+14% +$234K 0.6% 25
2025
Q3 		$1.24M Buy
170,000
+34,450
+25% +$279K 0.22% 39
2025
Q2 		$884K Buy
135,550
+22,000
+19% +$145K 0.19% 34
2025
Q1 		$917K Buy
113,550
+25,550
+29% +$279K 0.24% 33
2024
Q4 		$1.09M Buy
88,000
+39,166
+80% +$523K 0.25% 33
2024
Q3 		$400K Buy
+48,834
New +$292K 0.1% 53

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Privium Fund Management's WVE Position: Q2 2026 in Review

Privium Fund Management held its Wave Life Sciences (WVE) position steady in Q2 2026 at 241,010 shares worth $1.4M. The position accounts for 0.26% of the portfolio, ranked #40.

Privium Fund Management first reported a position in WVE in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.28M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Privium Fund Management held 241,010 shares of Wave Life Sciences worth $1.4M as of Q2 2026.
  • Privium Fund Management left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 0.26% of Privium Fund Management's portfolio in Q2 2026, its #40 holding.
  • Privium Fund Management first reported a position in Wave Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • Privium Fund Management's Wave Life Sciences position peaked at $3.28M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.